ATE386743T1 - Pyrimidoverbindungen mit antiproliferativer wirkung - Google Patents

Pyrimidoverbindungen mit antiproliferativer wirkung

Info

Publication number
ATE386743T1
ATE386743T1 AT03792269T AT03792269T ATE386743T1 AT E386743 T1 ATE386743 T1 AT E386743T1 AT 03792269 T AT03792269 T AT 03792269T AT 03792269 T AT03792269 T AT 03792269T AT E386743 T1 ATE386743 T1 AT E386743T1
Authority
AT
Austria
Prior art keywords
pyrimid
compounds
antiproliferative effect
antiproliferative
effect
Prior art date
Application number
AT03792269T
Other languages
English (en)
Inventor
Yi Chen
Andrzej Daniewski
William Harris
Marek Kabat
Emily Liu
Jin-Jun Liu
Kin-Chun Luk
Christophe Michoud
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE386743T1 publication Critical patent/ATE386743T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT03792269T 2002-08-14 2003-08-07 Pyrimidoverbindungen mit antiproliferativer wirkung ATE386743T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40351902P 2002-08-14 2002-08-14

Publications (1)

Publication Number Publication Date
ATE386743T1 true ATE386743T1 (de) 2008-03-15

Family

ID=31946709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03792269T ATE386743T1 (de) 2002-08-14 2003-08-07 Pyrimidoverbindungen mit antiproliferativer wirkung

Country Status (19)

Country Link
US (1) US7084270B2 (de)
EP (1) EP1556384B1 (de)
JP (1) JP2005538141A (de)
KR (1) KR20070087687A (de)
CN (1) CN1323080C (de)
AR (1) AR040971A1 (de)
AT (1) ATE386743T1 (de)
AU (1) AU2003255389A1 (de)
BR (1) BR0313732A (de)
CA (1) CA2494127A1 (de)
DE (1) DE60319255T2 (de)
ES (1) ES2300644T3 (de)
MX (1) MXPA05001629A (de)
PA (1) PA8580001A1 (de)
PL (1) PL375588A1 (de)
RU (1) RU2336275C2 (de)
TW (1) TW200407326A (de)
UY (1) UY27937A1 (de)
WO (1) WO2004018472A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008510690A (ja) 2004-08-31 2008-04-10 エフ.ホフマン−ラ ロシュ アーゲー 3−フェニル−ジヒドロピリミド[4,5−d]ピリミジノンのアミド誘導体、これらの製造、及び医薬品としての使用
BRPI0514750A (pt) 2004-08-31 2008-06-24 Hoffmann La Roche derivados amida de 7-amino-3-fenil-diidropirimido[4, 5-d]pirimidinonas, sua fabricação e uso como inibidores de proteìna cinase
WO2010099139A2 (en) 2009-02-25 2010-09-02 Osi Pharmaceuticals, Inc. Combination anti-cancer therapy
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US8465912B2 (en) 2009-02-27 2013-06-18 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
JP2014519813A (ja) 2011-04-25 2014-08-21 オーエスアイ・ファーマシューティカルズ,エルエルシー 癌薬剤発見、診断、および治療におけるemt遺伝子シグネチャーの使用
CN102816162B (zh) * 2011-06-10 2016-04-27 中国科学院广州生物医药与健康研究院 嘧啶并嘧啶酮类化合物及其药用组合物和应用
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
LT3495367T (lt) 2012-06-13 2021-02-25 Incyte Holdings Corporation Pakeistieji tricikliniai junginiai, kaip fgfr inhibitoriai
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
CN104968664A (zh) * 2012-12-12 2015-10-07 山东亨利医药科技有限责任公司 作为酪氨酸激酶抑制剂的并环化合物
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
US9321786B2 (en) 2013-03-15 2016-04-26 Celgene Avilomics Research, Inc. Heteroaryl compounds and uses thereof
CA2907243C (en) 2013-03-15 2021-12-28 Celgene Avilomics Research, Inc. Substituted dihydropyrimidopyrimidinone compounds and pharmaceutical compositions thereof use fgfr4 inhibitor
JP6576325B2 (ja) 2013-03-15 2019-09-18 セルジーン シーエーアール エルエルシー ヘテロアリール化合物およびそれらの使用
LT2986610T (lt) 2013-04-19 2018-04-10 Incyte Holdings Corporation Bicikliniai heterociklai, kaip fgfr inhibitoriai
CN104418860B (zh) * 2013-08-20 2016-09-07 中国科学院广州生物医药与健康研究院 嘧啶并杂环类化合物及其药用组合物和应用
DK3172213T3 (da) 2014-07-21 2021-12-13 Dana Farber Cancer Inst Inc Makrocykliske kinasehæmmere og anvendelser deraf
US10287268B2 (en) 2014-07-21 2019-05-14 Dana-Farber Cancer Institute, Inc. Imidazolyl kinase inhibitors and uses thereof
WO2016023014A2 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Uses of salt-inducible kinase (sik) inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
SG11201706287PA (en) 2015-02-20 2017-09-28 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
AU2017291812B2 (en) 2016-07-05 2023-12-14 Dana-Farber Cancer Institute, Inc. Bicyclic urea kinase inhibitors and uses thereof
US11241435B2 (en) 2016-09-16 2022-02-08 The General Hospital Corporation Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis
BR112019017741A2 (pt) 2017-02-28 2020-04-07 Dana Farber Cancer Inst Inc usos de pirimidopirimidinonas como inibidores de sik
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
ES3061844T3 (en) 2018-05-04 2026-04-07 Incyte Corp Salts of an fgfr inhibitor
MX2020011718A (es) 2018-05-04 2021-02-15 Incyte Corp Formas solidas de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr) y procesos para prepararlas.
PE20212303A1 (es) * 2018-12-27 2021-12-10 Les Laboratoires Servier Sas Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
TWI891666B (zh) 2019-10-14 2025-08-01 美商英塞特公司 作為fgfr抑制劑之雙環雜環
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021113462A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
TW202304459A (zh) 2021-04-12 2023-02-01 美商英塞特公司 包含fgfr抑制劑及nectin-4靶向劑之組合療法
EP4352060A1 (de) 2021-06-09 2024-04-17 Incyte Corporation Tricyclische heterocyclen als fgfr-inhibitoren
JP2024522189A (ja) 2021-06-09 2024-06-11 インサイト・コーポレイション Fgfr阻害剤としての三環式ヘテロ環

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2949466A (en) 1958-03-04 1960-08-16 Parke Davis & Co Pyrimidine compounds and means of producing the same
ES338687A1 (es) 1966-04-06 1968-04-01 Monsanto Co Procedimiento para obtener composiciones de fluidos funcio-nales.
US4425346A (en) 1980-08-01 1984-01-10 Smith And Nephew Associated Companies Limited Pharmaceutical compositions
JPS60226882A (ja) 1984-04-24 1985-11-12 Nippon Zoki Pharmaceut Co Ltd 新規ピリミドピリミジン誘導体
AU7622698A (en) 1996-12-05 1998-06-29 Sugen, Inc. Use of indolinone compounds as modulators of protein kinases
EE200000706A (et) 1998-05-26 2002-06-17 Warner-Lambert Company Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
CN1150195C (zh) 1998-10-23 2004-05-19 霍夫曼-拉罗奇有限公司 双环氮杂环
PL357494A1 (en) 1999-10-21 2004-07-26 F.Hoffmann-La Roche Ag Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
KR100523120B1 (ko) 1999-10-21 2005-10-20 에프. 호프만-라 로슈 아게 P38 단백질 키나제 저해제로서 헤테로알킬아미노-치환된이환 질소 헤테로환
MY141144A (en) 2000-03-02 2010-03-15 Smithkline Beecham Corp 1, 5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-dipyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
BR0113628A (pt) 2000-08-31 2003-07-01 Hoffmann La Roche 7-oxo-piridopirimidinas como inibidores de uma proliferação celular
US7196090B2 (en) 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors

Also Published As

Publication number Publication date
AU2003255389A1 (en) 2004-03-11
CN1323080C (zh) 2007-06-27
RU2336275C2 (ru) 2008-10-20
AR040971A1 (es) 2005-04-27
EP1556384A2 (de) 2005-07-27
CA2494127A1 (en) 2004-03-04
RU2005107314A (ru) 2005-11-20
TW200407326A (en) 2004-05-16
MXPA05001629A (es) 2005-04-25
JP2005538141A (ja) 2005-12-15
PL375588A1 (en) 2005-11-28
KR20070087687A (ko) 2007-08-28
WO2004018472A3 (en) 2004-04-29
CN1675214A (zh) 2005-09-28
UY27937A1 (es) 2004-02-27
ES2300644T3 (es) 2008-06-16
WO2004018472A2 (en) 2004-03-04
US7084270B2 (en) 2006-08-01
BR0313732A (pt) 2005-09-27
EP1556384B1 (de) 2008-02-20
DE60319255T2 (de) 2009-03-05
DE60319255D1 (de) 2008-04-03
US20040038995A1 (en) 2004-02-26
PA8580001A1 (es) 2004-03-10

Similar Documents

Publication Publication Date Title
DE60319255D1 (de) Pyrimidoverbindungen mit antiproliferativer wirkung
DE60332125D1 (de) Indole mit antidiabetischer wirkung
DE60318287D1 (de) Zerstäuber mit diskreten Strahlen
DE602004029705D1 (de) 5,7-diaminopyrazoloä4,3-düpyrimidine mit pde-5-hemmender wirkung
EP1546115A4 (de) Substituierte pyrimidine
EP1567871A4 (de) Sondenstation mit niederinduktivitätsweg
FI20020394A7 (fi) Valotutka
DK1487805T3 (da) Pyrimidinderivater
DE60319260D1 (de) Pyrimidoderivate mit antiproliferativer aktivität (ii)
ATE473985T1 (de) Tricyclische tetrahydrochinoline mit antibakterieller wirkung
EP1548905A4 (de) Lichtemittierendes element
ATE361282T1 (de) Indazol-aminoacetonitrilderivate mit pestizider wirkung
ATE446750T1 (de) 3-cyano-chinolin-derivate mit antiproliferativer wirkung
ATE435863T1 (de) Diazabicycloalkan-derivate mit nk1- antagonistischer wirkung
DE60315984D1 (de) Substituierte benzisoxazolsulfonamide mit breitbändiger hiv-protease hemmender wirkung
IS7421A (is) Frásogshvati
DE602004017199D1 (de) Silikonverbindungen mit mikrobizider wirkung
FR2844817B1 (fr) Element de coffrage
FI5659U1 (fi) Lana
ITUD20020081A1 (it) Profilo luminoso polifunzionale
ITUD20020026U1 (it) Profilo luminoso polifunzionale
FI5717U1 (fi) Kynttiläteline
ITRE20020018A1 (it) Denocciolatrice
DK1539233T3 (da) Humaniserede super-antistoffer
UA6164S (uk) Профіль

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1556384

Country of ref document: EP

REN Ceased due to non-payment of the annual fee